-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, at the 4th China International Import Expo, Sanofi Pasteur and Olive Branch Health reached a strategic cooperation and decided to jointly explore and create a digital ecology of vaccines
.
Specifically, it will focus on enhancing public awareness and acceptance of vaccines; supporting the improvement of digital service capabilities of the public health system, exploring innovative solutions for vaccination services such as unmanned vaccination cabins, and improving vaccine accessibility
.
It is understood that the integration between digital technology and various industries has become closer and closer in recent years, especially in the medical and health industry
.
In recent years, the operation of offline hospitals has been hindered by the epidemic, but the medical needs of the people have been increasing.
A large number of pharmaceutical companies are using the Internet and big data to accelerate their deployment in the direction of digitalization
.
Since the beginning of this year, in addition to Sanofi, there have been frequent news that multinational pharmaceutical giants are cooperating with domestic Internet medical companies in the industry
.
For example, on September 9, Chen Siying, head of AstraZeneca's e-commerce business, led a team to visit Dingdang Kuaiyao, and signed a 2022 strategic cooperation agreement with Dingdang Kuaiyao on the spot
.
The two parties announced that they will carry out in-depth cooperation based on the advantages of Dingdang Kuaiyao's integrated online and offline "digital pharmacy" model, the digitalization of pharmaceutical services, and AstraZeneca's outstanding drug research and development capabilities and years of experience in the health business field
.
On July 23, Novartis Pharmaceuticals and Ark Jianke Group reached a strategic cooperation
.
The two parties announced that they will carry out in-depth cooperation in drug services, disease management, and doctor-patient education around the "Quan Xin Quan Yi" project, and jointly explore the digital service model of "Internet + Heart Failure and Chronic Disease Management" to provide patients with a multi-faceted approach.
, Refined health management services
.
On July 9, Gilead Sciences also announced that it has reached a strategic cooperation with JD Health in the field of digital medical health ecology
.
The two parties will deeply explore the innovative practice of "Internet + medical health", and jointly provide more professional, safe and convenient "one-stop" disease management solutions for patients with chronic infectious diseases, and use this to accelerate HIV, chronic viral hepatitis and other infections Advancement of disease prevention and control
.
From the above point of view, digital technology is constantly developing in the medical industry.
At present, a large number of multinational pharmaceutical companies are cooperating with related digital technology companies to build related smart medical platforms at home and abroad and to upgrade their internal digitalization
.
It is worth mentioning that, from an overall perspective, domestic Internet medical companies have become key cooperation targets for multinational pharmaceutical companies
.
In this regard, industry analysts believe that the strategic layout of giants has always been the indicator of industry development
.
And multinational pharmaceutical companies with footprints all over the world are using artificial intelligence, machine learning, big data, electronic data collection and other technologies and platforms to accelerate the efficiency of drug research and development, accelerate the process of clinical trials, and narrow the relationship with doctors and patients.
In terms of relations, digital technology has become a new engine driving medical service innovation and is providing strong support for the establishment of a sound high-quality medical and health service system
.
The industry predicts that with the continuous advancement and development of technology, in the future, domestic and foreign pharmaceutical companies will accelerate the use of digital technologies, platforms to accelerate transformation and the ability to transform pharmaceutical scientific and technological achievements
.
However, it should be noted that the promotion of digital transformation is not a simple matter.
System customization is required.
It is necessary to use a systematic and scientific method to formulate a digital transformation strategy based on the company’s own development stage; at the same time, it is necessary to lay a solid foundation.
Digital talents are in place, data collection and frameworks are needed, and digital marketing platforms are needed
.
Therefore, if pharmaceutical companies want to transform into digital development, they must be prepared for a protracted battle
.
.
Specifically, it will focus on enhancing public awareness and acceptance of vaccines; supporting the improvement of digital service capabilities of the public health system, exploring innovative solutions for vaccination services such as unmanned vaccination cabins, and improving vaccine accessibility
.
It is understood that the integration between digital technology and various industries has become closer and closer in recent years, especially in the medical and health industry
.
In recent years, the operation of offline hospitals has been hindered by the epidemic, but the medical needs of the people have been increasing.
A large number of pharmaceutical companies are using the Internet and big data to accelerate their deployment in the direction of digitalization
.
Since the beginning of this year, in addition to Sanofi, there have been frequent news that multinational pharmaceutical giants are cooperating with domestic Internet medical companies in the industry
.
For example, on September 9, Chen Siying, head of AstraZeneca's e-commerce business, led a team to visit Dingdang Kuaiyao, and signed a 2022 strategic cooperation agreement with Dingdang Kuaiyao on the spot
.
The two parties announced that they will carry out in-depth cooperation based on the advantages of Dingdang Kuaiyao's integrated online and offline "digital pharmacy" model, the digitalization of pharmaceutical services, and AstraZeneca's outstanding drug research and development capabilities and years of experience in the health business field
.
On July 23, Novartis Pharmaceuticals and Ark Jianke Group reached a strategic cooperation
.
The two parties announced that they will carry out in-depth cooperation in drug services, disease management, and doctor-patient education around the "Quan Xin Quan Yi" project, and jointly explore the digital service model of "Internet + Heart Failure and Chronic Disease Management" to provide patients with a multi-faceted approach.
, Refined health management services
.
On July 9, Gilead Sciences also announced that it has reached a strategic cooperation with JD Health in the field of digital medical health ecology
.
The two parties will deeply explore the innovative practice of "Internet + medical health", and jointly provide more professional, safe and convenient "one-stop" disease management solutions for patients with chronic infectious diseases, and use this to accelerate HIV, chronic viral hepatitis and other infections Advancement of disease prevention and control
.
From the above point of view, digital technology is constantly developing in the medical industry.
At present, a large number of multinational pharmaceutical companies are cooperating with related digital technology companies to build related smart medical platforms at home and abroad and to upgrade their internal digitalization
.
It is worth mentioning that, from an overall perspective, domestic Internet medical companies have become key cooperation targets for multinational pharmaceutical companies
.
In this regard, industry analysts believe that the strategic layout of giants has always been the indicator of industry development
.
And multinational pharmaceutical companies with footprints all over the world are using artificial intelligence, machine learning, big data, electronic data collection and other technologies and platforms to accelerate the efficiency of drug research and development, accelerate the process of clinical trials, and narrow the relationship with doctors and patients.
In terms of relations, digital technology has become a new engine driving medical service innovation and is providing strong support for the establishment of a sound high-quality medical and health service system
.
The industry predicts that with the continuous advancement and development of technology, in the future, domestic and foreign pharmaceutical companies will accelerate the use of digital technologies, platforms to accelerate transformation and the ability to transform pharmaceutical scientific and technological achievements
.
However, it should be noted that the promotion of digital transformation is not a simple matter.
System customization is required.
It is necessary to use a systematic and scientific method to formulate a digital transformation strategy based on the company’s own development stage; at the same time, it is necessary to lay a solid foundation.
Digital talents are in place, data collection and frameworks are needed, and digital marketing platforms are needed
.
Therefore, if pharmaceutical companies want to transform into digital development, they must be prepared for a protracted battle
.
